Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Demyanenko, V. Romanov, S. Sheluhina, E. Shmelev, O. Lovacheva, M. Averbach (Moscow, Russian Federation). Clinical and immunological parameters in patients with newly diagnosed sarcoidosis. Eur Respir J 2013; 42: Suppl. 57, 3818

Member's Comments

No comment yet.

Related content which might interest you: Relationship between radiologic patterns, pulmonary function values and BALF cells in newly diagnosed sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Clinical approach to pulmonary sarcoidosis Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases Year: 2016 Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease (DILDs) Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 The role of the combined assessment of the bronchoalveolar lavage (BAL) and radiological profile in the diagnosis of chronic eosinophilic pneumonia (CEP) Source: Annual Congress 2013 –Modern approach to various clinical settings Year: 2013 Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful? Source: Eur Respir J 2011; 38: 761-769 Year: 2011 Clinical significance of hemosiderin-laden macrophages in bronchoalveolar lavage fluid of patients with idiopathic interstitial pneumonias Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Retrospective assessment of pulmonary sarcoidosis with the aid of bronchoalveolar lavage (BAL) during the past three-year period in a general hospital Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Usefulness of bronchoalveolar lavage in the diagnosis of desquamative interstitial pneumonia Source: International Congress 2014 – ILDs 2 Year: 2014 The impact of age on bronchoalveolar lavage (BAL) cytoimmunological pattern in interstitial lung diseases (ILD) and in healthy controls Source: International Congress 2014 – ILDs 4 Year: 2014 Eosinophilic lung disease Source: International Congress 2016 – Orphan diseases I Year: 2016 Bronchoalveolar lavage in children with diffuse lung disease Source: Annual Congress 2008 - The use of fibreoptic bronchoscopy in children with diffuse or localised lung disease Year: 2008 Is the severity of newly diagnosed pulmonary sarcoidosis reflected by bronchoalveolar lavage (BAL) parameters? Source: Eur Respir J 2001; 18: Suppl. 33, 507s Year: 2001 Is the severity of newly diagnosed pulmonary sarcoidosis reflected by bronchoalveolar lavage (BAL) parameters? Source: Eur Respir J 2002; 20: Suppl. 38, 468s Year: 2002 Usefulness of anti-Ro52 antibodies in the BAL of the patients with ILDs. Pilot study Source: International Congress 2016 – ILD pathogenesis Year: 2016 Correlations between the bronchoalveolar lavage cytology and lung function stage in newly diagnosed sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 538s Year: 2006 Bronchoalveolar lavage: how can we use it more effectively to define pathology? Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases Year: 2006 Bronchoalveolar lavage Source: Eur Respir Mon; 2010: 48: 59–72 Year: 2010 Indication of whole lung lavage in pulmonary alveolar proteinosis – Retrospective study Source: International Congress 2015 – IIPs: orphan Year: 2015 Bronchoalveolar lavage immunophenotyping improves diagnostic accuracy in patients with diffuse parenchymal lung disease Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010 Clinical, computed tomography, and cytological peculiarities of different variants of exogenic allergic alveolitis (EAA) Source: International Congress 2015 – Interstitial lung diseases I Year: 2015